Hims Hers Health (HIMS) Stock News

Jon Franklin, a CPA and former Rivian corporate controller, has joined Hims & Hers as Chief Accounting Officer. He will oversee the accounting organization as the company expands into new specialties and global markets, reporting to CFO Yemi Okupe. Franklin succeeds Irene Becklund, who announced her departure in July.

Glancy Prongay Wolke & Rotter LLP announced a class action lawsuit against Hims & Hers Health (HIMS) alleging undisclosed sharing of consumer health data with ad platforms and deceptive billing practices. Class period: August 4, 2025 to July 29, 2026. Lead plaintiff deadline: November 2, 2026.

A securities class action has been filed against Hims & Hers Health (HIMS) following the FTC's July 29 complaint alleging deceptive health data sharing and subscription billing practices. The stock dropped 14.7% that day. Lead plaintiff deadline is November 2, 2026.

Rosen Law Firm reminds Hims & Hers investors of the November 2 lead plaintiff deadline in the securities class action. The lawsuit alleges the company misled investors about sharing health data with third-party ad platforms and charging for prescriptions immediately after intake. The stock fell 14.7% on July 29 after the FTC announced a related complaint.

Hagens Berman announced a securities class action against Hims & Hers Health (HIMS) on behalf of investors who bought shares between Aug 4, 2025 and July 29, 2026. The lawsuit alleges the company misled investors about its data privacy practices and subscription billing, following an FTC complaint that accused Hims of sharing health data with Meta and Snap and violating ROSCA. The stock dropped 14.7% on July 29. Lead plaintiff deadline is Nov 2, 2026.

A securities class action has been filed against Hims & Hers Health (HIMS) following the FTC's July 29 complaint alleging deceptive health data sharing and subscription billing violations. The stock fell 14.7% that day. Class period: Aug 4, 2025 to July 29, 2026. Lead plaintiff deadline: Nov 2, 2026.

Hims & Hers Q2 revenue beats estimates, lifts full-year guidance.